跳至主要内容
临床试验/NCT02317952
NCT02317952已完成不适用

A Double-Blind, Randomized, Crossover Allergy Study of an Experimental Formula Followed by a 16 Week Double Blind Feeding Period to Assess Growth, Safety and Development of Tolerance to Cow's Milk Protein

Perrigo Nutritionals36 个研究点 分布在 1 个国家目标入组 90 人开始时间: 2014年5月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
90
试验地点
36
主要终点
Incidence of Allergic Reaction

研究概览

简要总结

The purpose of this study is to determine if a new extensively hydrolyzed formula can be consumed by children with Cow's Milk Allergy.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Other
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
— 至 13 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Good health
  • Parent/guardian must be willing to provide informed consent
  • Parent/guardian agrees to feed study formula provided
  • Confirmation of Cow's Milk Allergy

排除标准

  • No clinically significant abnormal findings on medical history, laboratory results, and physical exam.
  • No medications that may interfere with or impact evaluation of the study assessments
  • Allergy to extensively hydrolyzed casein formula
  • Tolerance of 200 ml of cow's milk, cow's milk-based formula or food products containing intact cow's milk protein within 2 weeks of the Screening Visit
  • Participation in another clinical trial within 30 days of screening where they are are receiving an active intervention

结局指标

主要结局

Incidence of Allergic Reaction

时间窗: 2 weeks

次要结局

  • Growth(16 weeks)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (36)

Loading locations...

相似试验

Formula for Children With Cow's Milk Allergy | 临床试验